Phase 3
A large study comparing a treatment against the current standard.
What it means
Phase 3 studies enrol the largest numbers, often across many hospitals and countries, and compare the new treatment against the current standard or a placebo.
Why it matters if you take part
These are the studies regulators typically rely on when deciding whether to approve a treatment. They are usually the closest to ordinary care in how often you are seen.
Related terms
Trials recruiting now that are Phase 3
743 recruiting trials in our Canadian corpus are Phase 3.
A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma
Asthma Control · PHASE3
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis · PHASE3
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Myelodysplastic Syndromes · PHASE3
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
Leukemia, Lymphocytic, Chronic, B-Cell · PHASE3
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema
Atopic Dermatitis · PHASE3
A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma
Relapsed Refractory Multiple Myeloma (RRMM) · PHASE3
This explains how clinical research works. It is not medical advice and does not describe any specific condition or treatment. Only a trial site can determine whether someone can take part in a study.